Skip to content

Evaluation of the curative effect of Daoyin therapy for lumbar disc herniation in the Department of Wei’s Traumatology

Evaluation of the curative effect of Daoyin therapy for lumbar disc herniation in the Department of Wei’s Traumatology

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077581
Enrollment
Unknown
Registered
2023-11-13
Start date
2023-11-20
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

control group:Wei's Two-Step Seven Manipulations
treatment group:Wei's Two-Step Seven Manipulations are followed by Wei's Daoyin

Sponsors

The Ruijin Hospital Afiliated to Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria, including clinical signs and imaging data, among which the diagnostic criteria of TCM: refer to the diagnostic criteria of LDH in the Diagnostic Efficacy Criteria of TCM Diseases; Diagnostic criteria for Western medicine: refer to the relevant contents of the "Consensus of Chinese pain Experts on the Diagnosis and Treatment of Lumbar disc Herniation". 2. Sign the dated informed consent, commit to abide by the research procedures, and cooperate with the implementation of the whole process of research. 3, age 18-50 years old. 4. Patients with unilateral low back pain or numbness of back and leg pain.

Exclusion criteria

Exclusion criteria: 1, can not cooperate with the completion of data collection or incomplete data; 2. Patients with lumbar spine fracture, or local bone diseases such as tuberculosis and tumor; 3, with cardiovascular, liver, kidney or hematopoietic system and other serious primary diseases. Other autoimmune diseases, allergic diseases, acute and chronic infections; 4, mental patients, or female patients with severe menopausal symptoms; 5. Pregnant or lactating women; 6. Experimental studies of other treatments for this disease are being conducted within 2 weeks.

Design outcomes

Primary

MeasureTime frame
effective rate;

Secondary

MeasureTime frame
Japanese Orthopaedic Association Scores ,JOA;Visual analogue scale,VAS;The Oswestry Disability Index,ODI;Soft tissue hardness;Pain threshold;

Countries

China

Contacts

Public ContactQiang Wang

The Ruijin Hospital Afiliated to Shanghai JiaoTong University School of Medicine

18817939781@163.com+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026